Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 613

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 613
---
 credits and unused tax losses can be utilized. The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re -assessedat each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered. Deferred tax is measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates that have been enacted or substantively enacted at the balance sheet date. The Group has concluded not to recognize deferred tax assets due to the improbability of future taxable amounts being available to offset those temporary differences and losses. F-108 Notes to Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 2.Summary of significant accounting policies and basis of preparation (cont.) 2.19 Expenses Sales and marketing expenses, general and administrative expenses, and research and development expenses The Group recognizes expenses in the period in which these costs are incurred and are presented by function on the statements of operations. Sales and marketing expenses primarily relate to marketing materials and research the Group generates to increase brand awareness and commercialize its services in the marketplace. Administrative expenses primarily comprise professional fees (mainly related to consultancy, accountancy and legal expenses), payroll compensation to certain executives. Other operating expenses relate to those that do not depend on general business operations or relate to the other expense categories. 2.20 Segment reporting The Group operates in two business segments, a direct -to -consumersegment named “Rewell”, and a business -to -businesssegment named “Heritas Diagnostics”. Under IFRS 8 (Segment Information), the Group’s operating segments are reported in a manner consistent with the internal reporting provided to the Chief Operating Decision Maker (“CODM”) which, in the case of the Group, is the Executive Team. The Executive Team is composed of a Chief Executive Officer, a Chief Science Officer, and a Chief Financial Officer. The CODM is responsible for allocating resources and assessing performance of the business. See Note 21 for further details. 3.Financial risk management Overview: The Group has exposure to the following risks from its use of financial instruments: •Credit risk •Liquidity risk •Market risk This note presents quantitative and qualitative information about the Group’s exposure to each of the above risks, and the Group